None listed
Conditions
Interventions
None listed
Sponsors
Bharat Biotech International Limited BBIL
Clinical Research Network India CRO
Eligibility
Inclusion criteria
Inclusion criteria: Families which have children in the age group 6 to 18 years. Intention of being available for entire study period
Exclusion criteria
Exclusion criteria: Children with any chronic illness, disorder, or condition that in the opinion of the investigator may affect the safety of the participant or the evaluation of any study endpoint. Unable to comprehend the questions Unable to provide written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and frequency (infection rate) of symptomatic COVID-19 infection in children from fully vaccinated, partially vaccinated, and unvaccinated cohort from both rural and urban areas (separately and combined). Severity of COVID-19 infection in children from fully vaccinated, partially vaccinated, and unvaccinated cohort observed from both rural and urban areas (separately and combined). Timepoint: The subject and their families will be followed up for every 30 days for a period of one year as per the pre-decided schedule. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number and frequency (infection rate) of reinfection in children from fully vaccinated, partially vaccinated, and unvaccinated cohort from both rural and urban areas (separately and combined). Correlation/association of COVID-19 with select socio-demographic groups.Timepoint: The subject and their families will be followed up for every 30 days for a period of one year as per the pre-decided schedule. | — |
Countries
India
Contacts
Public ContactDr Nidhi Singh
Bharat Biotech International Ltd
Outcome results
None listed